Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia

Affiliations

• ¹ Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf and German CLL Study Group, University of Cologne, Germany.
• ² Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Germany.
• ³ Department of Internal Medicine III, Ulm University, Ulm, Germany.
• ⁴ Oncology Lerchenfeld Clinic, Hamburg, Germany.
• ⁵ Department of Medicine II, University of Schleswig-Holstein, Kiel, Germany.
• ⁶ Gemeinschaftspraxis für Hämatologie und Onkologie, Clemenshospital Münster, Düesbergweg, Germany.
• ⁷ Department of Internal Medicine I, Klinikum am Steinenberg, Reutlingen, Germany.
• ⁸ Praxis Fuer Onkologie, Saarbrücken, Germany.
• ⁹ Department of Hematology and Oncology, DIAKO Hospital Bremen, Germany.
• ¹⁰ Department of Medicine V, University Hospital Heidelberg, Germany.
• ¹¹ Gilead Sciences, Inc., Foster City, California, USA.